difference in semaglutide vs tirzepatide Comparative safety and side effects of and tirzepatide: Implications for clinical decision-making obesity management Semaglutide vs. Tirzepatide: What's the

For the weekly injection (2.4 mg), the STEP 1 trial showed sustained, clinically relevant weight reduction versus placebo in adults with overweight or obesity, as published in PubMed and in The New England Journal of Medicine

Participants were randomized to receive either 9 weeks of semaglutide or placebo

Theyll be able to give you informed feedback about whether you should increase your dose or even try a different approach, such as tirzepatide, in lieu of your current protocol

This is accomplished because there are receptors for this hormone at the stomach, which delays gastric emptying, and in parts of the brain, which triggers a decrease in the desire to eat